A multicenter, prospective, randomized controlled trial of intracranial hemorrhage risk of intensive statin therapy in patients with acute ischemic stroke combined with cerebral microbleeds (CHRISTMAS): Study protocol
BackgroundLow serum levels of major lipid markers have been proved to be significantly associated with increased risks of hemorrhagic stroke (HS) and cerebral microbleeds (CMBs). However, there is no lipid modification guideline telling us how to maintain a balance between the prevention of ischemic...
Main Authors: | Jia-ling Zhao, Chi-bo Ai, Li Wang, Shao-jie Yang, Jian Wang, Wei Yang, Jie Tang, Ling Zhang, Yan Li, Ting-qi Yan, Shu Gou, Gui-gui Xie, Yang Xiang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-02-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2023.1097078/full |
Similar Items
-
Vertebrobasilar dolichoectasia in patients with cerebrovascular ischemic stroke: does it have a role in cerebral microbleeds?
by: Ahmed Osama, et al.
Published: (2022-12-01) -
Cerebral Microbleeds Assessment and Quantification in COVID-19 Patients With Neurological Manifestations
by: Angela Napolitano, et al.
Published: (2022-05-01) -
Low-density lipoprotein cholesterol, statin therapy, and cerebral microbleeds: The CIRCLE study
by: Yuqi Zhao, et al.
Published: (2023-01-01) -
Intracranial hemorrhage with concurrent aortic dissection
by: Amro Abdelrahman, MD, et al.
Published: (2023-01-01) -
Statins and 90-Day Functional Performance and Survival in Patients with Spontaneous Intracerebral Hemorrhage
by: Karolina Zaryczańska, et al.
Published: (2023-10-01)